United Therapeutics Corporation (UTHR)

Pretax margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm)	US$ in thousands	1,539,000	1,437,900	1,401,100	1,381,000	1,274,300	1,157,700	1,118,400	933,800	950,600	912,300	804,200	870,100	593,900	567,800	582,400	499,800	638,900	592,800	540,700	657,200
Revenue (ttm)	US$ in thousands	2,877,400	2,756,200	2,616,700	2,498,300	2,327,500	2,204,300	2,110,900	1,981,300	1,936,300	1,860,000	1,788,700	1,768,300	1,685,500	1,655,200	1,590,600	1,506,100	1,483,300	1,409,500	1,430,900	1,442,500
Pretax margin		53.49%	52.17%	53.54%	55.28%	54.75%	52.52%	52.98%	47.13%	49.09%	49.05%	44.96%	49.21%	35.24%	34.30%	36.62%	33.19%	43.07%	42.06%	37.79%	45.56%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $1,539,000K ÷ $2,877,400K
= 53.49%

The pretax margin of United Therapeutics Corporation has shown fluctuations over the past few years, ranging from a low of 33.19% in March 2021 to a high of 55.28% in March 2024. The trend in pretax margins demonstrates some variability, with periods of both decline and growth.

Throughout the observed period, there appears to be a general upward trend in pretax margin performance, especially notable in the latter half of the data range. This increase indicates that the company has been more efficient in generating profits before accounting for taxes.

It is important to note that pretax margin is a key indicator of a company's operational efficiency and profitability. A higher pretax margin suggests better cost management and more effective revenue generation. However, fluctuations in this metric could be influenced by various factors such as changes in revenue, operating expenses, or tax strategies.

Overall, United Therapeutics Corporation's pretax margin has been relatively healthy and has shown improvement over time, reflecting positively on the company's financial performance and management strategies. Further analysis could provide insights into the specific drivers behind these fluctuations and trends, helping stakeholders better understand the company's financial health and potential future prospects.